Literature DB >> 12390326

Elevated production of interleukin-18 is associated with renal disease in patients with systemic lupus erythematosus.

C K Wong1, C Y Ho, E K Li, L S Tam, C W K Lam.   

Abstract

To investigate the production mechanism and proinflammatory role of the cytokine interleukin (IL-18) in lupus nephritis, we investigated the plasma concentrations of IL-18 and nitric oxide (NO) and the release of IL-18 and NO from mitogen-activated peripheral blood monomuclear cells (PBMC), in 35 SLE patients with renal disease (RSLE), 37 patients without renal disease (SLE) and 28 sex- and age-matched healthy control subjects (NC). IL-18 and NO concentrations were measured by ELISA and colourimetric non-enzymatic assay, respectively. Gene expressions of IL-18 and IL-18 receptor were analysed by RT-PCR. Plasma IL-18 and NO concentrations were significantly higher in RSLE than NC (both P < 0.01). Elevation of plasma IL-18 in RSLE correlated positively and significantly with SLE -disease activity index and plasma NO concentration (r = 0.623, P < 0.0001 and r = 0.455, P = 0.017, respectively), and the latter also showed a positive and significant correlation with plasma creatinine (r = 0.410, P = 0.034) and urea (r = 0.685, P < 0.0001). There was no significant difference in gene expressions of IL-18 and IL-18 receptor in PBMC among RSLE, SLE and NC. Percentage increase in culture supernatant IL-18 concentration was significantly higher in RSLE than SLE and NC (both P < 0.05). The basal NO release was significantly higher in RSLE than that in SLE and NC (both P < 0.005). IL-18 is therefore suggested to play a crucial role in the inflammatory processes of renal disease in SLE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390326      PMCID: PMC1906516          DOI: 10.1046/j.1365-2249.2002.01989.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  Purification and characterization of the human interleukin-18 receptor.

Authors:  K Torigoe; S Ushio; T Okura; S Kobayashi; M Taniai; T Kunikata; T Murakami; O Sanou; H Kojima; M Fujii; T Ohta; M Ikeda; H Ikegami; M Kurimoto
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

Review 2.  IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family.

Authors:  C A Dinarello
Journal:  J Allergy Clin Immunol       Date:  1999-01       Impact factor: 10.793

3.  Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE).

Authors:  J F Viallard; J L Pellegrin; V Ranchin; T Schaeverbeke; J Dehais; M Longy-Boursier; J M Ragnaud; B Leng; J F Moreau
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

4.  Circulating levels of beta-chemokines in systemic lupus erythematosus.

Authors:  H Kaneko; H Ogasawara; T Naito; H Akimoto; S Lee; T Hishikawa; I Sekigawa; Y Tokano; Y Takasaki; S I Hirose; H Hashimoto
Journal:  J Rheumatol       Date:  1999-03       Impact factor: 4.666

5.  Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus.

Authors:  E M Davas; A Tsirogianni; I Kappou; D Karamitsos; I Economidou; P C Dantis
Journal:  Clin Rheumatol       Date:  1999       Impact factor: 2.980

6.  Impaired production of IL-12 in system lupus erythematosus. II: IL-12 production in vitro is correlated negatively with serum IL-10, positively with serum IFN-gamma and negatively with disease activity in SLE.

Authors:  T F Liu; B M Jones
Journal:  Cytokine       Date:  1998-02       Impact factor: 3.861

7.  Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus.

Authors:  H M Belmont; D Levartovsky; A Goel; A Amin; R Giorno; J Rediske; M L Skovron; S B Abramson
Journal:  Arthritis Rheum       Date:  1997-10

8.  Correlation of serum measures of nitric oxide production with lupus disease activity.

Authors:  G Gilkeson; C Cannon; J Oates; C Reilly; D Goldman; M Petri
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

Review 9.  Cytokines in the pathogenesis of systemic lupus erythematosus.

Authors:  V R Kelley; R P Wüthrich
Journal:  Semin Nephrol       Date:  1999-01       Impact factor: 5.299

10.  Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells.

Authors:  D Xu; W L Chan; B P Leung; D Hunter; K Schulz; R W Carter; I B McInnes; J H Robinson; F Y Liew
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  18 in total

1.  Association between interleukin 18 polymorphisms and alopecia areata in Koreans.

Authors:  Su Kang Kim; Hae Jeong Park; Joo-Ho Chung; Jong Woo Kim; Hosik Seok; Bark-Lynn Lew; Woo-Young Sim
Journal:  J Interferon Cytokine Res       Date:  2014-01-21       Impact factor: 2.607

2.  Expressions of IL-18 and its binding protein in peripheral blood leukocytes and kidney tissues of lupus nephritis patients.

Authors:  Dawei Hu; Xiaoqian Liu; Shunle Chen; Chunde Bao
Journal:  Clin Rheumatol       Date:  2010-02-08       Impact factor: 2.980

3.  Retinal self-antigen induces a predominantly Th1 effector response in Axl and Mertk double-knockout mice.

Authors:  Fei Ye; Lixia Han; Qingjun Lu; Wanwei Dong; Zhenwen Chen; Hui Shao; Henry J Kaplan; Qiutang Li; Qingxian Lu
Journal:  J Immunol       Date:  2011-09-14       Impact factor: 5.422

4.  Interleukin-18 overexpression as a hallmark of the activity of autoimmune inflammatory myopathies.

Authors:  M Tucci; C Quatraro; F Dammacco; F Silvestris
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

5.  Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis.

Authors:  Jim C Oates; Stephanie R Shaftman; Sally E Self; Gary S Gilkeson
Journal:  Arthritis Rheum       Date:  2008-01

6.  IL-18 105 A>C polymorphism contributes to renal manifestations in patients with SLE.

Authors:  Teresa Warchoł; Margarita Lianeri; Mariusz Wudarski; Jan K Lacki; Paweł Piotr Jagodziński
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

7.  Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis.

Authors:  N Calvani; H B Richards; M Tucci; G Pannarale; F Silvestris
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

8.  Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis.

Authors:  M Tucci; L Lombardi; H B Richards; F Dammacco; F Silvestris
Journal:  Clin Exp Immunol       Date:  2008-09-15       Impact factor: 4.330

9.  Activation profile of intracellular mitogen-activated protein kinases in peripheral lymphocytes of patients with systemic lupus erythematosus.

Authors:  Chun K Wong; Purple T Y Wong; L S Tam; Edmund K Li; D P Chen; Christopher W K Lam
Journal:  J Clin Immunol       Date:  2009-11       Impact factor: 8.317

Review 10.  IL-18 in inflammatory and autoimmune disease.

Authors:  Saikiran K Sedimbi; Thomas Hägglöf; Mikael C I Karlsson
Journal:  Cell Mol Life Sci       Date:  2013-07-27       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.